아비타 메디컬(RCEL)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $11.02 (-1.78%), 시가총액 $0.13B, 52주 최저~최고 $3.27 ~ $6.76.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a l
아비타 메디컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
아비타 메디컬의 현재 주가는 $11.02 (-1.78%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
아비타 메디컬의 시가총액은 약 $0.13B입니다.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company'